We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutr... Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Show more
Abbott Laboratories (NYSE:ABT) reported on Wednesday a notable increase in its first quarter sales for 2024, which rose by 2.2% to reach $9.9 billion, surpassing analysts’ expectations...
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges PR Newswire ABBOTT PARK, Ill., April 17, 2024 Sales of $10.0 billion driven by strong underlying base...
U.S. index futures displayed positive performance in pre-market trading on Wednesday, with S&P 500 aiming to halt a downward trend that persisted over the last three consecutive days. As of...
Taiwan Semiconductor Manufacturing Company (NYSE:TSM) – TSMC evacuated some factories and suspended operations after a 7.4 magnitude earthquake hit Taiwan, raising concerns about the global...
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve PR Newswire ABBOTT PARK, Ill., April 2, 2024 TriClip offers a remarkably safe, minimally...
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside PR Newswire ABBOTT PARK, Ill., April 1, 2024 The test, run on Abbott's...
Abbott Hosts Conference Call for First-Quarter Earnings PR Newswire ABBOTT PARK, Ill., March 27, 2024 ABBOTT PARK, Ill., March 27, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its...
Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et...
Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 Diabetes PR Newswire ABBOTT PARK, Ill., March 6, 2024 Data analyses show...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.4 | -3.07775866751 | 110.47 | 110.89 | 104.25 | 8340790 | 107.04534128 | CS |
4 | -3.33 | -3.01630434783 | 110.4 | 114.02 | 104.25 | 6034770 | 109.86980741 | CS |
12 | -5.33 | -4.74199288256 | 112.4 | 121.64 | 104.25 | 5937240 | 113.32793528 | CS |
26 | 10.2 | 10.52957572 | 96.87 | 121.64 | 91.64 | 5730166 | 108.51619826 | CS |
52 | -4.68 | -4.18791946309 | 111.75 | 121.64 | 89.674 | 5287485 | 106.3787983 | CS |
156 | -15.74 | -12.8165458839 | 122.81 | 142.6 | 89.674 | 5394080 | 111.67518685 | CS |
260 | 33.94 | 46.410501846 | 73.13 | 142.6 | 61.61 | 5540069 | 104.16964425 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions